Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leshan Sanjiu Long March Pharmaceuticals is a prominent Chinese pharmaceutical manufacturer specializing in anti-infective drugs, particularly semi-synthetic penicillins and cephalosporins. Founded in 1966 as the Long March Pharmaceutical Factory, it has evolved into a core production base for China Resources Sanjiu Medical & Pharmaceutical. The company operates large-scale facilities for both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, including sterile powders for injection and oral tablets. Its products are distributed globally, supported by robust fermentation and chemical synthesis technologies. As a subsidiary of a major state-owned enterprise, it plays a significant role in the Chinese antibiotic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leshan Sanjiu Long March Pharmaceuticals.